查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1954069

日本非处方药市场规模、份额、趋势及预测（依产品类型、给药途径、剂型、通路及地区划分，2026-2034年）

Japan Over The Counter (OTC) Drugs Market Size, Share, Trends and Forecast by Product Type, Route of Administration, Dosage Form, Distribution Channel, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2025年，日本非处方药市场规模达110.84亿美元。 IMARC集团预测，到2034年，该市场规模将达到172.325亿美元，2026年至2034年的复合年增长率为5.03%。推动市场成长的因素包括人口快速老化、健康意识增强、文明病增加、产品配方创新、政府有利的监管政策、预防性医疗保健的广泛应用、电子商务的普及以及消费者对天然和有机药物的需求增长。

日本非处方药市场趋势：

人口老化加剧

人口老化正显着影响非处方药市场，并推动人们对自我护理解决方案的需求。这是加速日本非处方药市场成长的关键因素之一。截至2024年9月，日本65岁以上人口将达到创纪录的3,625万，占总人口的29.3%。这老年人人口往往面临高血压、关节炎和糖尿病等慢性疾病的困扰。随着医疗成本的持续上涨和住院治疗选择的减少，越来越多的老年人开始依赖成药来自主管理常见症状。非处方药的便利性和经济性促使老年人转向自我保健，使患者能够避免频繁前往医疗机构。日本完善的医疗保健基础设施进一步强化了这一趋势，确保了非处方药在药局和药局的广泛供应。

提高健康意识

消费者健康意识的提升是推动日本非处方药（OTC）市场占有率成长的主要因素之一。越来越多的人在寻求医疗干预之前，选择自行处理轻微的健康问题，这促进了市场成长。此外，人们对自我护理保健益处的认识不断提高，包括使用成药治疗感冒、消化器官系统问题和轻微疼痛等常见疾病，进一步加速了这一趋势。日本人越来越意识到文明病的风险，并积极寻求预防措施。媒体健康内容的增加、数位管道资讯的普及以及政府的健康宣传活动也推动了消费者在成药上的支出。这些预防措施带动了对多种非处方药产品的需求成长，包括维生素、免疫力增强剂和护肤品，推动了市场扩张。

拓展零售通路

零售通路的扩张是推动市场成长的关键因素。例如，2025年1月，日本零售额年增3.9%，连续第34个月实现成长。成药透过如此广泛的零售通路网路销售，让消费者无需就医即可轻鬆获得所需药品。药局是最受欢迎的管道之一，提供各式各样的产品，满足消费者从止痛药到个人保养用品等各种需求。此外，网路零售的兴起带来了更丰富的产品选择、更便捷的价格比较以及宅配服务，进一步提振了日本非处方药市场的前景。同时，分销管道的扩张有助于市场渗透到不同人群，并促进市场竞争。这反过来又鼓励产品创新和改进，从而进一步刺激市场成长。

本报告解答的关键问题

  • 日本非处方药市场目前发展状况如何？您认为未来几年它将如何发展？
  • 日本非处方成药）市场按产品类型分類的组成是什么？
  • 日本非处方成药）市场是如何依给药途径细分的？
  • 日本非处方成药市场按剂型是如何分類的？
  • 日本非处方成药）市场按通路分類的组成是怎样的？
  • 日本非处方成药市场按地区分類的情况如何？
  • 请介绍日本非处方药市场价值链的各个环节。
  • 日本非处方成药市场的主要驱动因素和挑战是什么？
  • 日本非处方药市场的结构是怎么样的？主要参与者有哪些？
  • 日本非处方药市场竞争有多激烈？

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
  • 市场估值
  • 调查方法

第三章执行摘要

第四章：日本非处方药市场：引言

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争资讯

第五章：日本非处方药市场概况

  • 过去和当前的市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章：日本非处方药市场：依产品类型划分

  • 咳嗽、感冒和流感产品
  • 止痛药
  • 皮肤科产品
  • 胃肠病学
  • 维生素、矿物质和补充剂 (VMS)
  • 减重和饮食产品
  • 眼科产品
  • 助眠剂
  • 其他的

第七章：日本非处方药市场－依给药途径细分

  • 口服
  • 注射
  • 外用
  • 其他的

第八章：日本非处方药市场－依剂型细分

  • 片剂和胶囊
  • 液体
  • 软膏
  • 其他的

第九章 日本非处方药市场－依销售管道细分

  • 医院药房
  • 零售药房
  • 网路药房
  • 其他的

第十章：日本非处方药市场：依地区划分

  • 关东地区
  • 关西、近畿地区
  • 中部地区
  • 九州和冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第十一章：日本非处方药市场：竞争格局

  • 概述
  • 市场结构
  • 市场公司定位
  • 关键成功策略
  • 竞争对手仪錶板
  • 企业估值象限

第十二章主要企业概况

第十三章：日本非处方药市场：产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十四章附录

简介目录
Product Code: SR112026A33582

The Japan over the counter (OTC) drugs market size reached USD 11,084.0 Million in 2025 . Looking forward, IMARC Group expects the market to reach USD 17,232.5 Million by 2034 , exhibiting a growth rate (CAGR) of 5.03% during 2026-2034 . Burgeoning aging population, surging health awareness, rising lifestyle diseases, innovation in product formulations, favorable government regulations, the popularity of preventive healthcare, growing e-commerce adoption, and a shift toward natural, organic drug alternatives are factors propelling the market growth.

JAPAN OVER THE COUNTER (OTC) DRUGS MARKET TRENDS:

Growing Geriatric Population

The aging population significantly influences the OTC drug market, driving the demand for self-care solutions, which is one of the key factors accelerating the Japan over the counter (OTC) drugs market growth. As of September 2024, Japan's elderly population reached a record high of 36.25 million individuals aged 65 or older, accounting for 29.3% of the total population. The elderly demographic, which constitutes a considerable portion of the population, often faces chronic health issues such as hypertension, arthritis, and diabetes. As healthcare costs continue to rise and the availability of in-patient treatments becomes more limited, many seniors are turning to OTC drugs for managing common ailments independently. The shift towards self-medication among older adults is encouraged by the convenience and affordability of OTC products, which allow them to avoid frequent visits to healthcare providers. This trend is further compounded by Japan's well-established healthcare infrastructure, which supports widespread access to OTC drugs in drugstores and pharmacies.

Increased Health Awareness

Increasing health consciousness among consumers is one of the primary factors fostering the growth of the Japan over the counter (OTC) drugs market share. An increasing number of people are opting for preventative healthcare and seeking to mitigate minor health issues themselves before resorting to medical intervention, which is boosting the market growth. This is further fueled by the escalating awareness of the advantages of staying well via self-care, which encompasses the use of OTC medicines to treat common ailments like colds, digestive problems and minor aches. The Japanese are becoming increasingly cognizant of the likelihood of lifestyle diseases and searching for ways to prevent them. Consumers' willingness to spend on OTC medications has also been driven by the increased amount of health-related content in the media, the availability of information via digital channels, as well as government health campaigns. This trend of preventative measures has led to a higher demand for several OTC products like vitamins, immunity boosters and skincare treatments which are also driving the market expansion.

Retail Channel Expansion

The expansion of retail channels is a crucial factor driving the market growth. For instance, retail sales in Japan advanced by 3.9% year-on-year in January 2025, marking the 34th consecutive month of growth. The availability of OTC drugs through such a broad network of retail channels has made it easier for consumers to access the products they need without visiting a doctor. Drugstores are among the most popular channels, offering a variety of products that cater to diverse consumer needs, from pain relievers to personal care items. Additionally, the rise of online retail has allowed for greater product selection, better price comparison, and doorstep delivery, further creating a positive Japan over the counter (OTC) drugs market outlook. Moreover, the expansion of distribution channels supports market penetration across different demographics and encourages competition, which drives innovation and improvement in product offerings, which is further stimulating the market growth.

JAPAN OVER THE COUNTER (OTC) DRUGS MARKET SEGMENTATION:

Product Type Insights:

  • Cough, Cold and Flu Products
  • Analgesics
  • Dermatology Products
  • Gastrointestinal Products
  • Vitamins, Minerals and Supplements (VMS)
  • Weight-loss/Dietary Products
  • Ophthalmic Products
  • Sleeping Aids
  • Others

Route Of Administration Insights:

  • Oral
  • Parenteral
  • Topical

Dosage Form Insights:

  • Tablets and Capsules
  • Liquids
  • Ointments

Distribution Channel Insights:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

  • KEY QUESTIONS ANSWERED IN THIS REPORT
  • How has the Japan over the counter (OTC) drugs market performed so far and how will it perform in the coming years?
  • What is the breakup of the Japan over the counter (OTC) drugs market on the basis of product type?
  • What is the breakup of the Japan over the counter (OTC) drugs market on the basis of route of administration?
  • What is the breakup of the Japan over the counter (OTC) drugs market on the basis of dosage form?
  • What is the breakup of the Japan over the counter (OTC) drugs market on the basis of distribution channel?
  • What is the breakup of the Japan over the counter (OTC) drugs market on the basis of region?
  • What are the various stages in the value chain of the Japan over the counter (OTC) drugs market?
  • What are the key driving factors and challenges in the Japan over the counter (OTC) drugs market?
  • What is the structure of the Japan over the counter (OTC) drugs market and who are the key players?
  • What is the degree of competition in the Japan over the counter (OTC) drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Over The Counter (OTC) Drugs Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Over The Counter (OTC) Drugs Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Over The Counter (OTC) Drugs Market - Breakup by Product Type

  • 6.1 Cough, Cold and Flu Products
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Analgesics
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Dermatology Products
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 Gastrointestinal Products
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 Vitamins, Minerals and Supplements (VMS)
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2020-2025)
    • 6.5.3 Market Forecast (2026-2034)
  • 6.6 Weight-loss/Dietary Products
    • 6.6.1 Overview
    • 6.6.2 Historical and Current Market Trends (2020-2025)
    • 6.6.3 Market Forecast (2026-2034)
  • 6.7 Ophthalmic Products
    • 6.7.1 Overview
    • 6.7.2 Historical and Current Market Trends (2020-2025)
    • 6.7.3 Market Forecast (2026-2034)
  • 6.8 Sleeping Aids
    • 6.8.1 Overview
    • 6.8.2 Historical and Current Market Trends (2020-2025)
    • 6.8.3 Market Forecast (2026-2034)
  • 6.9 Others
    • 6.9.1 Historical and Current Market Trends (2020-2025)
    • 6.9.2 Market Forecast (2026-2034)

7 Japan Over The Counter (OTC) Drugs Market - Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Parenteral
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Topical
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Others
    • 7.4.1 Historical and Current Market Trends (2020-2025)
    • 7.4.2 Market Forecast (2026-2034)

8 Japan Over The Counter (OTC) Drugs Market - Breakup by Dosage Form

  • 8.1 Tablets and Capsules
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Liquids
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Ointments
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)
  • 8.4 Others
    • 8.4.1 Historical and Current Market Trends (2020-2025)
    • 8.4.2 Market Forecast (2026-2034)

9 Japan Over The Counter (OTC) Drugs Market - Breakup by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Forecast (2026-2034)
  • 9.2 Retail Pharmacies
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Forecast (2026-2034)
  • 9.3 Online Pharmacies
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Forecast (2026-2034)
  • 9.4 Others
    • 9.4.1 Historical and Current Market Trends (2020-2025)
    • 9.4.2 Market Forecast (2026-2034)

10 Japan Over The Counter (OTC) Drugs Market - Breakup by Region

  • 10.1 Kanto Region
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2020-2025)
    • 10.1.3 Market Breakup by Product Type
    • 10.1.4 Market Breakup by Route of Administration
    • 10.1.5 Market Breakup by Dosage Form
    • 10.1.6 Market Breakup by Distribution Channel
    • 10.1.7 Key Players
    • 10.1.8 Market Forecast (2026-2034)
  • 10.2 Kansai/Kinki Region
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2020-2025)
    • 10.2.3 Market Breakup by Product Type
    • 10.2.4 Market Breakup by Route of Administration
    • 10.2.5 Market Breakup by Dosage Form
    • 10.2.6 Market Breakup by Distribution Channel
    • 10.2.7 Key Players
    • 10.2.8 Market Forecast (2026-2034)
  • 10.3 Central/ Chubu Region
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2020-2025)
    • 10.3.3 Market Breakup by Product Type
    • 10.3.4 Market Breakup by Route of Administration
    • 10.3.5 Market Breakup by Dosage Form
    • 10.3.6 Market Breakup by Distribution Channel
    • 10.3.7 Key Players
    • 10.3.8 Market Forecast (2026-2034)
  • 10.4 Kyushu-Okinawa Region
    • 10.4.1 Overview
    • 10.4.2 Historical and Current Market Trends (2020-2025)
    • 10.4.3 Market Breakup by Product Type
    • 10.4.4 Market Breakup by Route of Administration
    • 10.4.5 Market Breakup by Dosage Form
    • 10.4.6 Market Breakup by Distribution Channel
    • 10.4.7 Key Players
    • 10.4.8 Market Forecast (2026-2034)
  • 10.5 Tohoku Region
    • 10.5.1 Overview
    • 10.5.2 Historical and Current Market Trends (2020-2025)
    • 10.5.3 Market Breakup by Product Type
    • 10.5.4 Market Breakup by Route of Administration
    • 10.5.5 Market Breakup by Dosage Form
    • 10.5.6 Market Breakup by Distribution Channel
    • 10.5.7 Key Players
    • 10.5.8 Market Forecast (2026-2034)
  • 10.6 Chugoku Region
    • 10.6.1 Overview
    • 10.6.2 Historical and Current Market Trends (2020-2025)
    • 10.6.3 Market Breakup by Product Type
    • 10.6.4 Market Breakup by Route of Administration
    • 10.6.5 Market Breakup by Dosage Form
    • 10.6.6 Market Breakup by Distribution Channel
    • 10.6.7 Key Players
    • 10.6.8 Market Forecast (2026-2034)
  • 10.7 Hokkaido Region
    • 10.7.1 Overview
    • 10.7.2 Historical and Current Market Trends (2020-2025)
    • 10.7.3 Market Breakup by Product Type
    • 10.7.4 Market Breakup by Route of Administration
    • 10.7.5 Market Breakup by Dosage Form
    • 10.7.6 Market Breakup by Distribution Channel
    • 10.7.7 Key Players
    • 10.7.8 Market Forecast (2026-2034)
  • 10.8 Shikoku Region
    • 10.8.1 Overview
    • 10.8.2 Historical and Current Market Trends (2020-2025)
    • 10.8.3 Market Breakup by Product Type
    • 10.8.4 Market Breakup by Route of Administration
    • 10.8.5 Market Breakup by Dosage Form
    • 10.8.6 Market Breakup by Distribution Channel
    • 10.8.7 Key Players
    • 10.8.8 Market Forecast (2026-2034)

11 Japan Over The Counter (OTC) Drugs Market - Competitive Landscape

  • 11.1 Overview
  • 11.2 Market Structure
  • 11.3 Market Player Positioning
  • 11.4 Top Winning Strategies
  • 11.5 Competitive Dashboard
  • 11.6 Company Evaluation Quadrant

12 Profiles of Key Players

  • 12.1 Company A
    • 12.1.1 Business Overview
    • 12.1.2 Products Offered
    • 12.1.3 Business Strategies
    • 12.1.4 SWOT Analysis
    • 12.1.5 Major News and Events
  • 12.2 Company B
    • 12.2.1 Business Overview
    • 12.2.2 Products Offered
    • 12.2.3 Business Strategies
    • 12.2.4 SWOT Analysis
    • 12.2.5 Major News and Events
  • 12.3 Company C
    • 12.3.1 Business Overview
    • 12.3.2 Products Offered
    • 12.3.3 Business Strategies
    • 12.3.4 SWOT Analysis
    • 12.3.5 Major News and Events
  • 12.4 Company D
    • 12.4.1 Business Overview
    • 12.4.2 Products Offered
    • 12.4.3 Business Strategies
    • 12.4.4 SWOT Analysis
    • 12.4.5 Major News and Events
  • 12.5 Company E
    • 12.5.1 Business Overview
    • 12.5.2 Products Offered
    • 12.5.3 Business Strategies
    • 12.5.4 SWOT Analysis
    • 12.5.5 Major News and Events

13 Japan Over The Counter (OTC) Drugs Market - Industry Analysis

  • 13.1 Drivers, Restraints, and Opportunities
    • 13.1.1 Overview
    • 13.1.2 Drivers
    • 13.1.3 Restraints
    • 13.1.4 Opportunities
  • 13.2 Porters Five Forces Analysis
    • 13.2.1 Overview
    • 13.2.2 Bargaining Power of Buyers
    • 13.2.3 Bargaining Power of Suppliers
    • 13.2.4 Degree of Competition
    • 13.2.5 Threat of New Entrants
    • 13.2.6 Threat of Substitutes
  • 13.3 Value Chain Analysis

14 Appendix